OROJIN Launches at BIOHK 2025, Promising AI Biomarker Revolution

OROJIN Launches at BIOHK 2025, Promising AI Biomarker Revolution

Five millilitre blood sample predicts illness five years ahead, giving clinicians fresh SEO fodder around preventive medicine and Hong Kong biotech breakthroughs.